The combined analysis of TP53-, LOH1p/19q and IDH1 in a large series of recurrent gliomas aimed at elucidating the type and frequency of inter- and intratumoral dynamics of these molecular alterations during tumor progression. This evidence concerns the gene TP53 and central nervous system cancer.